The average P/S ratio for MDGL's competitors is 5.18, providing a benchmark for relative valuation. Madrigal Pharmaceuticals Inc Corp (MDGL) exhibits a P/S ratio of 9.41, which is 81.81% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.